Interní Med. 2010; 12(7-8): 366-368

Iron - friend or foe of the men?

doc.MUDr.Radana Neuwirtová, CSc.1, prof.MUDr.Přemysl Poňka, Ph.D.2
1 I. interní klinika VFN Praha
2 Dept. of Physiology and Medicine, McGill University, Montreal

In the review article new findings in pathophysiology of iron and in iron overload diseases are presented. Iron may play a role either as

a friend or a foe of the men.

Keywords: Fe – transport and storrage, toxic oxygen radicals, hepcidin, anemia of chronic diseases, haemochromatoses, sideroblastic anemia

Published: August 12, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Neuwirtová R, Poňka P. Iron - friend or foe of the men? Interní Med. 2010;12(7-8):366-368.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Štípek S, a kol. Antioxidanty a volné radikály ve zdraví a nemoci. Grada Publishing Praha, 2000; 70-71.
    2. Beutler E. Disorders of Iron Metabolism. Williams Hematology, McGraw-Hill, Med. Publ. Division, 8. Ed., 2009; kapitola 42.
    3. Cannone-Hergaux S, Zhang AS, Ponka P, Gross P. Characterization of the iron transporter DMT 1 in red blood cells of normal and anemic mk/mk mice. Blood 2001; 98: 3823-3830. Go to original source... Go to PubMed...
    4. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306: 2090-2093. Go to original source... Go to PubMed...
    5. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 2001; 276: 7806-7810. Go to original source... Go to PubMed...
    6. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783-788. Go to original source... Go to PubMed...
    7. Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006; 91: 727-732. Go to PubMed...
    8. Peslova G, Petrak J, Kuzelova K, et al. Hepcidin, the hormone of iron metabolism, is bound specifically to ?-2macroglobulin in blood. Blood 2009; 113: 6225-6236. Go to original source... Go to PubMed...
    9. Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood 2008; 112: 4292-4297. Go to original source... Go to PubMed...
    10. Tanno T, Bhanu NV, Oneal PA, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nature Medicine 2007; 13: 1096-1011. Go to original source... Go to PubMed...
    11. Tanno T, Porayette P, Sripichal O, et al. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 2009; 114: 181-186. Go to original source... Go to PubMed...
    12. Adamson JW. The anemia of inflammation/malignancy: mechanism and management. Hematology Am. Soc. Hematol. Educ. Program 2008; 159-165. Go to original source... Go to PubMed...
    13. Ganz T, Nemeth E. Iron sequestartion and anemia of inflammation. Semin. Hematol. 2009; 46: 387-393. Go to original source... Go to PubMed...
    14. Theurl I, Mattle V, Seifert M, et al. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood 2006; 107: 4142-4148. Go to original source... Go to PubMed...
    15. Pietrangelo A. Hereditary Hemochromatosis - A New Look at an Old Disease. N. Eng. J. Med 2004; 350: 2383-2397. Go to original source... Go to PubMed...
    16. Čermák J. Některé nové poznatky v diagnostice a léčbě stavů s přetížením železem. Trans. Hemat. dnes 2006; 12: 140-145.
    17. Mahesh S, Ginzburg Y, Verma A. Iron overload in myelodysplastic syndromes. Leukemia a Lymphoma 2008; 49: 427-438. Go to original source... Go to PubMed...
    18. Cazzola M, DellaPorta MG, Malcovati L. Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes. Hematology Am. Soc. Hematol. Educ. Program 2008; 166-175. Go to original source... Go to PubMed...
    19. Gattermann N. Iron overload in MDS, clinical consequences and management strategies. Leukemia Research 2007; 31(suppl. 3): S1-S16. Go to original source... Go to PubMed...
    20. Jonášová A. Doporučení pro chelatační léčbu u chronicky transfundovaných hematologických nemocných se známkami přetížení železem. Farmakoterapie 2008; 4: 1-6.
    21. Levi S, Corsi B, Bossisio M, et al. A human mitochondrial ferritin encoded by an intronless gene. J. Biol. Chem. 2001; 276: 24437-24440. Go to original source... Go to PubMed...
    22. Cazzola M, Invernizzi R, Bergamaschi G, et al. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 2003; 101: 1996-2000. Go to original source... Go to PubMed...
    23. Napier I, Ponka P, Richardson DesR. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 2005; 105: 1867-1874. Go to original source... Go to PubMed...
    24. Boulwood J, Pellagatti A, Nikpour M, et al. The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts. PloS One 2008; 3: 1-5. Go to original source...
    25. Bergamaschi G, Villani L. Serum hepcidin: a novel diagnostic tool in disorders of iron metabolism. Haematologica 2009; 94: 1631-1633. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.